share_log

Evercore ISI Group Downgrades Cabaletta Bio to In-Line, Lowers Price Target to $6

Benzinga ·  06:37  · Ratings

Evercore ISI Group analyst Gavin Clark-Gartner downgrades Cabaletta Bio (NASDAQ:CABA) from Outperform to In-Line and lowers the price target from $15 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment